Blood thinners are medications that reduce your body’s ability to form blood clots. Despite the name, they don’t actually thin your blood. They work by interfering with either the clotting proteins in your blood or the tiny cell fragments called platelets that clump together to seal wounds. Doctors prescribe them to prevent dangerous clots from forming in your veins, arteries, heart, or lungs.
Two Types That Work Differently
Blood thinners fall into two broad categories: anticoagulants and antiplatelets. The distinction matters because they target completely different parts of the clotting process and are used for different conditions.
Anticoagulants slow down the chain reaction of clotting proteins that builds a clot. The oldest and most well-known is warfarin, which blocks vitamin K, a nutrient your body needs to produce several of those clotting proteins. Newer options, often called direct oral anticoagulants (DOACs), include apixaban (Eliquis), rivaroxaban (Xarelto), dabigatran (Pradaxa), and edoxaban (Savaysa). These newer drugs block a single, specific clotting protein rather than working through vitamin K.
Antiplatelets prevent platelets from sticking together. Aspirin is the most common example. Others include clopidogrel (Plavix), ticagrelor (Brilinta), and prasugrel (Effient). These are mainly prescribed to people who have had a heart attack or stroke, since platelet clumps play a central role in blocking already-narrowed arteries.
Why Doctors Prescribe Them
The most common reason is an irregular heart rhythm called atrial fibrillation, where the upper chambers of the heart quiver instead of beating effectively. Blood pools in those chambers, and pooled blood clots. If a clot breaks free and travels to the brain, it causes a stroke. Anticoagulants dramatically reduce that risk.
Other conditions that call for blood thinners include deep vein thrombosis (a clot in a leg vein), a blood clot in the lungs (pulmonary embolism), certain heart or blood vessel diseases, heart valve replacements, congenital heart defects, and a heightened clot risk after surgery. Your specific condition determines which type you’ll take and for how long.
Newer Drugs vs. Warfarin
For decades, warfarin was the only oral anticoagulant available. It still works well, but it requires regular blood tests to make sure the dose is right, and it interacts with many foods and other medications. The newer DOACs have largely replaced warfarin for most patients because they don’t need routine blood monitoring and have fewer dietary restrictions.
European and American guidelines now recommend DOACs over warfarin for stroke prevention in patients with atrial fibrillation and most types of heart valve disease. Warfarin remains the first-line choice in two specific situations: moderate to severe rheumatic mitral stenosis and mechanical heart valves. If you have a mechanical valve, DOACs are not safe for you.
Bleeding risk differs between these medications. In patients with atrial fibrillation and severe kidney disease, apixaban was associated with a major bleeding rate of about 1.5 per 100 people per year, compared to 2.9 for warfarin and 4.9 for rivaroxaban. That makes apixaban roughly half as likely to cause a major bleed as warfarin in that population, according to research published in the Journal of the American Heart Association.
Monitoring on Warfarin
If you take warfarin, you’ll need periodic blood draws to check your INR (International Normalized Ratio), which measures how long your blood takes to clot. For most conditions, the target INR is between 2.0 and 3.0. Below 2.0 means your blood is clotting too easily and you’re not adequately protected. Above 3.0 means your blood is too slow to clot and your bleeding risk rises.
When you first start warfarin, you’ll have blood drawn frequently, sometimes weekly, until your dose stabilizes. Once steady, testing may move to every few weeks. The goal is to spend as much time as possible within that therapeutic range, which requires consistent habits around diet and timing. Warfarin should be taken at the same time every day.
DOACs skip this process entirely. They’re taken at fixed doses, and routine blood monitoring isn’t necessary. That convenience is a major reason they’ve become the default choice.
Foods and Drinks That Interfere
Warfarin’s biggest lifestyle challenge is vitamin K. Because warfarin works by blocking vitamin K, eating significantly more or less of it than usual can push your clotting out of range. You don’t need to avoid vitamin K-rich foods altogether. You just need to keep your intake roughly consistent from week to week.
Foods particularly high in vitamin K include:
- Kale, spinach, and Swiss chard
- Broccoli and Brussels sprouts
- Collard greens, mustard greens, and turnip greens
- Asparagus and seaweed
The recommended daily intake of vitamin K is 120 micrograms for men and 90 micrograms for women. A single cup of raw kale contains several times that amount, so a sudden kale smoothie habit could meaningfully reduce warfarin’s effectiveness.
Certain drinks also interact with warfarin. Alcohol, cranberry juice, grapefruit juice, and even chamomile or green tea can increase bleeding risk and should be limited or avoided. DOACs have far fewer dietary interactions, though some (like rivaroxaban) need to be taken with food to absorb properly.
Bleeding Risk on Blood Thinners
Every blood thinner increases your risk of bleeding, because that’s inherently what they do. Most bleeding events are minor: nosebleeds, bleeding gums, easy bruising, or cuts that take longer to stop. These are common and usually manageable.
Major bleeding is less common but serious. It can include blood in your urine or stool, vomiting blood, or bleeding in the brain. For context, the annual major bleeding rate on apixaban is roughly 1.5 per 100 patients, meaning about 98 to 99 out of 100 people taking it won’t experience a major bleed in a given year. The risk is real but needs to be weighed against the risk of stroke or clot, which these medications exist to prevent.
If a major bleed does happen, hospitals have reversal agents that can counteract each type of blood thinner. Warfarin can be reversed with vitamin K and clotting factor concentrates. Dabigatran has a specific antidote called idarucizumab that works within minutes. Apixaban and rivaroxaban can be reversed with clotting factor concentrates or, in some cases, a targeted reversal agent called andexanet alfa. The existence of these reversal options is one reason doctors feel comfortable prescribing blood thinners even in higher-risk patients.
Stopping Before Surgery
If you need surgery or a procedure, your blood thinner will likely need to be paused beforehand so you don’t bleed excessively. How far in advance depends on which medication you take.
Warfarin should be stopped at least five days before a procedure, regardless of whether the surgery carries low or high bleeding risk. That long timeline reflects how slowly warfarin leaves your system.
DOACs clear the body much faster. For procedures with low to moderate bleeding risk, stopping one day before is typically enough. For high-risk surgeries, two days. If your kidneys don’t filter as efficiently (which is common in older adults), dabigatran may need to be stopped three to four days ahead.
Antiplatelet medications follow their own schedules. Aspirin can often be continued through surgery, but clopidogrel should be held for five days, ticagrelor for three to five days, and prasugrel for seven to ten days. For procedures with minimal bleeding risk, like certain dental work or skin biopsies, DOACs can sometimes be continued without interruption. Your surgical team will give you specific instructions based on both the medication and the procedure.